Hyloris Revenue and Competitors
Estimated Revenue & Valuation
- Hyloris's estimated annual revenue is currently $10.3M per year.
- Hyloris's estimated revenue per employee is $201,000
Employee Data
- Hyloris has 51 Employees.
- Hyloris grew their employee count by 6% last year.
Hyloris's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Regulatory Strategy | Reveal Email/Phone |
2 | VP Clinical Affairs | Reveal Email/Phone |
3 | VP Investor Relations and Corporate Communications | Reveal Email/Phone |
4 | Head R&D | Reveal Email/Phone |
5 | IP Director | Reveal Email/Phone |
6 | Director Project Management | Reveal Email/Phone |
7 | Senior Manager, Regulatory Strategy | Reveal Email/Phone |
8 | Clinical Project Manager | Reveal Email/Phone |
9 | Clinical Project Manager | Reveal Email/Phone |
10 | Project Manager | Reveal Email/Phone |
Hyloris Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is Hyloris?
Hyloris is an early-stage innovative specialty pharmaceutical company focused on adding value to the healthcare system by reformulating well-known pharmaceuticals. Hyloris develops proprietary products it believes offer significant advantages compared to currently available alternatives, with the aim to address the underserved medical needs of patients, hospitals, physicians, payors and other stakeholders in the healthcare system. Hyloris' portfolio spans three areas of focus: IV Cardiovascular, Other Reformulations and Established Market (high-barrier generics).
keywords:N/AN/A
Total Funding
51
Number of Employees
$10.3M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Hyloris News
Value-added medicines firm Hyloris has raised 15m from new and existing investors through a private equity offering of nearly one million...
Hyloris is a specialty biopharma company focused on innovating, reinventing, and optimising existing medications to address important healthcare...
LIÈGE, Belgium, March 31, 2022 (GLOBE NEWSWIRE) -- Hyloris Pharmaceuticals SA (Euronext Brussels: HYL) (the Company or Hyloris), a specialty...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.5M | 83 | 2% | N/A |
#2 | $34.2M | 148 | 4% | N/A |
#3 | $123.8M | 450 | 17% | N/A |
#4 | $102.6M | 662 | 8% | N/A |
#5 | $203.4M | 835 | 9% | N/A |